IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS...
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study
About this item
Full title
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study
Author / Creator
Publisher
Poland: Wydawnictwo Via Medica
Journal title
Cardiology journal, 2022-01, Vol.29 (1), p.140-147
Language
English
Formats
Publication information
Publisher
Poland: Wydawnictwo Via Medica
Subjects
More information
Alternative Titles
Full title
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8890419
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8890419
Other Identifiers
ISSN
1897-5593
E-ISSN
1898-018X
DOI
10.5603/CJ.a2021.0148
